Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report

摘要

IntroductionChronic hepatitis C is a leading cause of severe liver disease. Protease inhibitors used to treat these patients are known to have many drug interactions, although there is limited data available between boceprevir and warfarin. This case report is the first in vivo drug interaction reported in the literature.